Cargando…

Transmission Dynamics of HIV-1 Drug Resistance among Treatment-Naïve Individuals in Greece: The Added Value of Molecular Epidemiology to Public Health

The presence of human immunodeficiency virus type 1 (HIV-1) drug resistance among drug-naïve patients remains stable, although the proportion of patients with virological failure to therapy is decreasing. The dynamics of transmitted resistance among drug-naïve patients remains largely unknown. The p...

Descripción completa

Detalles Bibliográficos
Autores principales: Paraskevis, Dimitrios, Kostaki, Evangelia, Gargalianos, Panagiotis, Xylomenos, Georgios, Lazanas, Marios, Chini, Maria, Skoutelis, Athanasios, Papastamopoulos, Vasileios, Paraskeva, Dimitra, Antoniadou, Anastasia, Papadopoulos, Antonios, Psichogiou, Mina, Daikos, Georgios L., Chrysos, Georgios, Paparizos, Vasileios, Kourkounti, Sofia, Sambatakou, Helen, Sipsas, Nikolaos V., Lada, Malvina, Panagopoulos, Periklis, Maltezos, Efstratios, Drimis, Stylianos, Hatzakis, Angelos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704235/
https://www.ncbi.nlm.nih.gov/pubmed/29137167
http://dx.doi.org/10.3390/genes8110322
_version_ 1783281848847171584
author Paraskevis, Dimitrios
Kostaki, Evangelia
Gargalianos, Panagiotis
Xylomenos, Georgios
Lazanas, Marios
Chini, Maria
Skoutelis, Athanasios
Papastamopoulos, Vasileios
Paraskeva, Dimitra
Antoniadou, Anastasia
Papadopoulos, Antonios
Psichogiou, Mina
Daikos, Georgios L.
Chrysos, Georgios
Paparizos, Vasileios
Kourkounti, Sofia
Sambatakou, Helen
Sipsas, Nikolaos V.
Lada, Malvina
Panagopoulos, Periklis
Maltezos, Efstratios
Drimis, Stylianos
Hatzakis, Angelos
author_facet Paraskevis, Dimitrios
Kostaki, Evangelia
Gargalianos, Panagiotis
Xylomenos, Georgios
Lazanas, Marios
Chini, Maria
Skoutelis, Athanasios
Papastamopoulos, Vasileios
Paraskeva, Dimitra
Antoniadou, Anastasia
Papadopoulos, Antonios
Psichogiou, Mina
Daikos, Georgios L.
Chrysos, Georgios
Paparizos, Vasileios
Kourkounti, Sofia
Sambatakou, Helen
Sipsas, Nikolaos V.
Lada, Malvina
Panagopoulos, Periklis
Maltezos, Efstratios
Drimis, Stylianos
Hatzakis, Angelos
author_sort Paraskevis, Dimitrios
collection PubMed
description The presence of human immunodeficiency virus type 1 (HIV-1) drug resistance among drug-naïve patients remains stable, although the proportion of patients with virological failure to therapy is decreasing. The dynamics of transmitted resistance among drug-naïve patients remains largely unknown. The prevalence of non-nucleoside reverse transcriptase inhibitors (NNRTI) resistance was 16.9% among treatment-naïve individuals in Greece. We aimed to investigate the transmission dynamics and the effective reproductive number (R(e)) of the locally transmitted NNRTI resistance. We analyzed sequences with dominant NNRTI resistance mutations (E138A and K103N) found within monophyletic clusters (local transmission networks (LTNs)) from patients in Greece. For the K103N LTN, the R(e) was >1 between 2008 and the first half of 2013. For all E138A LTNs, the R(e) was >1 between 1998 and 2015, except the most recent one (E138A_4), where the R(e) was >1 between 2006 and 2011 and approximately equal to 1 thereafter. K103N and E138A_4 showed similar characteristics with a more recent origin, higher R(e) during the first years of the sub-epidemics, and a declining trend in the number of transmissions during the last two years. In the remaining LTNs the epidemic was still expanding. Our study highlights the added value of molecular epidemiology to public health.
format Online
Article
Text
id pubmed-5704235
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-57042352017-11-30 Transmission Dynamics of HIV-1 Drug Resistance among Treatment-Naïve Individuals in Greece: The Added Value of Molecular Epidemiology to Public Health Paraskevis, Dimitrios Kostaki, Evangelia Gargalianos, Panagiotis Xylomenos, Georgios Lazanas, Marios Chini, Maria Skoutelis, Athanasios Papastamopoulos, Vasileios Paraskeva, Dimitra Antoniadou, Anastasia Papadopoulos, Antonios Psichogiou, Mina Daikos, Georgios L. Chrysos, Georgios Paparizos, Vasileios Kourkounti, Sofia Sambatakou, Helen Sipsas, Nikolaos V. Lada, Malvina Panagopoulos, Periklis Maltezos, Efstratios Drimis, Stylianos Hatzakis, Angelos Genes (Basel) Article The presence of human immunodeficiency virus type 1 (HIV-1) drug resistance among drug-naïve patients remains stable, although the proportion of patients with virological failure to therapy is decreasing. The dynamics of transmitted resistance among drug-naïve patients remains largely unknown. The prevalence of non-nucleoside reverse transcriptase inhibitors (NNRTI) resistance was 16.9% among treatment-naïve individuals in Greece. We aimed to investigate the transmission dynamics and the effective reproductive number (R(e)) of the locally transmitted NNRTI resistance. We analyzed sequences with dominant NNRTI resistance mutations (E138A and K103N) found within monophyletic clusters (local transmission networks (LTNs)) from patients in Greece. For the K103N LTN, the R(e) was >1 between 2008 and the first half of 2013. For all E138A LTNs, the R(e) was >1 between 1998 and 2015, except the most recent one (E138A_4), where the R(e) was >1 between 2006 and 2011 and approximately equal to 1 thereafter. K103N and E138A_4 showed similar characteristics with a more recent origin, higher R(e) during the first years of the sub-epidemics, and a declining trend in the number of transmissions during the last two years. In the remaining LTNs the epidemic was still expanding. Our study highlights the added value of molecular epidemiology to public health. MDPI 2017-11-13 /pmc/articles/PMC5704235/ /pubmed/29137167 http://dx.doi.org/10.3390/genes8110322 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Paraskevis, Dimitrios
Kostaki, Evangelia
Gargalianos, Panagiotis
Xylomenos, Georgios
Lazanas, Marios
Chini, Maria
Skoutelis, Athanasios
Papastamopoulos, Vasileios
Paraskeva, Dimitra
Antoniadou, Anastasia
Papadopoulos, Antonios
Psichogiou, Mina
Daikos, Georgios L.
Chrysos, Georgios
Paparizos, Vasileios
Kourkounti, Sofia
Sambatakou, Helen
Sipsas, Nikolaos V.
Lada, Malvina
Panagopoulos, Periklis
Maltezos, Efstratios
Drimis, Stylianos
Hatzakis, Angelos
Transmission Dynamics of HIV-1 Drug Resistance among Treatment-Naïve Individuals in Greece: The Added Value of Molecular Epidemiology to Public Health
title Transmission Dynamics of HIV-1 Drug Resistance among Treatment-Naïve Individuals in Greece: The Added Value of Molecular Epidemiology to Public Health
title_full Transmission Dynamics of HIV-1 Drug Resistance among Treatment-Naïve Individuals in Greece: The Added Value of Molecular Epidemiology to Public Health
title_fullStr Transmission Dynamics of HIV-1 Drug Resistance among Treatment-Naïve Individuals in Greece: The Added Value of Molecular Epidemiology to Public Health
title_full_unstemmed Transmission Dynamics of HIV-1 Drug Resistance among Treatment-Naïve Individuals in Greece: The Added Value of Molecular Epidemiology to Public Health
title_short Transmission Dynamics of HIV-1 Drug Resistance among Treatment-Naïve Individuals in Greece: The Added Value of Molecular Epidemiology to Public Health
title_sort transmission dynamics of hiv-1 drug resistance among treatment-naïve individuals in greece: the added value of molecular epidemiology to public health
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704235/
https://www.ncbi.nlm.nih.gov/pubmed/29137167
http://dx.doi.org/10.3390/genes8110322
work_keys_str_mv AT paraskevisdimitrios transmissiondynamicsofhiv1drugresistanceamongtreatmentnaiveindividualsingreecetheaddedvalueofmolecularepidemiologytopublichealth
AT kostakievangelia transmissiondynamicsofhiv1drugresistanceamongtreatmentnaiveindividualsingreecetheaddedvalueofmolecularepidemiologytopublichealth
AT gargalianospanagiotis transmissiondynamicsofhiv1drugresistanceamongtreatmentnaiveindividualsingreecetheaddedvalueofmolecularepidemiologytopublichealth
AT xylomenosgeorgios transmissiondynamicsofhiv1drugresistanceamongtreatmentnaiveindividualsingreecetheaddedvalueofmolecularepidemiologytopublichealth
AT lazanasmarios transmissiondynamicsofhiv1drugresistanceamongtreatmentnaiveindividualsingreecetheaddedvalueofmolecularepidemiologytopublichealth
AT chinimaria transmissiondynamicsofhiv1drugresistanceamongtreatmentnaiveindividualsingreecetheaddedvalueofmolecularepidemiologytopublichealth
AT skoutelisathanasios transmissiondynamicsofhiv1drugresistanceamongtreatmentnaiveindividualsingreecetheaddedvalueofmolecularepidemiologytopublichealth
AT papastamopoulosvasileios transmissiondynamicsofhiv1drugresistanceamongtreatmentnaiveindividualsingreecetheaddedvalueofmolecularepidemiologytopublichealth
AT paraskevadimitra transmissiondynamicsofhiv1drugresistanceamongtreatmentnaiveindividualsingreecetheaddedvalueofmolecularepidemiologytopublichealth
AT antoniadouanastasia transmissiondynamicsofhiv1drugresistanceamongtreatmentnaiveindividualsingreecetheaddedvalueofmolecularepidemiologytopublichealth
AT papadopoulosantonios transmissiondynamicsofhiv1drugresistanceamongtreatmentnaiveindividualsingreecetheaddedvalueofmolecularepidemiologytopublichealth
AT psichogioumina transmissiondynamicsofhiv1drugresistanceamongtreatmentnaiveindividualsingreecetheaddedvalueofmolecularepidemiologytopublichealth
AT daikosgeorgiosl transmissiondynamicsofhiv1drugresistanceamongtreatmentnaiveindividualsingreecetheaddedvalueofmolecularepidemiologytopublichealth
AT chrysosgeorgios transmissiondynamicsofhiv1drugresistanceamongtreatmentnaiveindividualsingreecetheaddedvalueofmolecularepidemiologytopublichealth
AT paparizosvasileios transmissiondynamicsofhiv1drugresistanceamongtreatmentnaiveindividualsingreecetheaddedvalueofmolecularepidemiologytopublichealth
AT kourkountisofia transmissiondynamicsofhiv1drugresistanceamongtreatmentnaiveindividualsingreecetheaddedvalueofmolecularepidemiologytopublichealth
AT sambatakouhelen transmissiondynamicsofhiv1drugresistanceamongtreatmentnaiveindividualsingreecetheaddedvalueofmolecularepidemiologytopublichealth
AT sipsasnikolaosv transmissiondynamicsofhiv1drugresistanceamongtreatmentnaiveindividualsingreecetheaddedvalueofmolecularepidemiologytopublichealth
AT ladamalvina transmissiondynamicsofhiv1drugresistanceamongtreatmentnaiveindividualsingreecetheaddedvalueofmolecularepidemiologytopublichealth
AT panagopoulosperiklis transmissiondynamicsofhiv1drugresistanceamongtreatmentnaiveindividualsingreecetheaddedvalueofmolecularepidemiologytopublichealth
AT maltezosefstratios transmissiondynamicsofhiv1drugresistanceamongtreatmentnaiveindividualsingreecetheaddedvalueofmolecularepidemiologytopublichealth
AT drimisstylianos transmissiondynamicsofhiv1drugresistanceamongtreatmentnaiveindividualsingreecetheaddedvalueofmolecularepidemiologytopublichealth
AT hatzakisangelos transmissiondynamicsofhiv1drugresistanceamongtreatmentnaiveindividualsingreecetheaddedvalueofmolecularepidemiologytopublichealth